Identification of hub pathways and drug candidates in gastric cancer through systems biology

Gastric cancer is the fourth cause of cancer death globally, and gastric adenocarcinoma is its most common type. Efforts for the treatment of gastric cancer have increased its median survival rate by only seven months. Due to the relatively low response of gastric cancer to surgery and adjuvant ther...

Descripción completa

Detalles Bibliográficos
Autores principales: Salarikia, Seyed Reza, Kashkooli, Mohammad, Taghipour, Mohammad Javad, Malekpour, Mahdi, Negahdaripour, Manica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9160265/
https://www.ncbi.nlm.nih.gov/pubmed/35650297
http://dx.doi.org/10.1038/s41598-022-13052-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9160265/
https://www.ncbi.nlm.nih.gov/pubmed/35650297
http://dx.doi.org/10.1038/s41598-022-13052-0

Ejemplares similares